Long-term disability outcomes in relapsing-remitting multiple sclerosis: a 10-year follow-up study

被引：0
|
作者：
Jelena Drulovic
Jovana Ivanovic
Sarlota Mesaros
Vanja Martinovic
Darija Kisic-Tepavcevic
Irena Dujmovic
Tatjana Pekmezovic
机构：
[1] Clinical Center of Serbia,Clinic of Neurology
[2] University of Belgrade,Faculty of Medicine
[3] University of Belgrade,Institute of Epidemiology, Faculty of Medicine
来源：
Neurological Sciences | 2019年 / 40卷
关键词：
Multiple sclerosis; Interferon beta; Disability; Prediction; Long-term follow-up; Relapse rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1627 / 1636
页数：9
相关论文
共 50 条
  • [1] Long-term disability outcomes in relapsing-remitting multiple sclerosis: A 10-year follow-up study
    Drulovic, Jelena
    Pekmezovic, Tatjana
    Mesaros, Sarlota
    Dujmovic, Irena
    Martinovic, Vanja
    Ivanovic, Jovana
    Hellwig, Kerstin
    NEUROLOGY, 2018, 90
  • [2] Long-term disability outcomes in relapsing-remitting multiple sclerosis: a 10-year follow-up study
    Drulovic, Jelena
    Ivanovic, Jovana
    Mesaros, Sarlota
    Martinovic, Vanja
    Kisic-Tepavcevic, Darija
    Dujmovic, Irena
    Pekmezovic, Tatjana
    NEUROLOGICAL SCIENCES, 2019, 40 (08) : 1627 - 1636
  • [3] Interferon-beta and worsening disability in relapsing-remitting multiple sclerosis: 10-year follow-up study
    Drulovic, J.
    Mesaros, S.
    Dujmovic, I.
    Martinovic, V.
    Pekmezovic, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 790 - 791
  • [4] Long-term follow-up of laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Ashtamker, N.
    Sidi, Y.
    Ladkani, D.
    Gorfine, T.
    Sorensen, P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 39 - 39
  • [5] Long-term follow-up of laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Lublin, F. D.
    Dadon, Y.
    Gorfine, T.
    Davis, M. D.
    Sorensen, P. S.
    Knappertz, V.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 122 - 123
  • [6] Long-term follow-up of immunomodulatory therapies in early relapsing-remitting multiple sclerosis
    Haas, Judith
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S45 - S46
  • [7] Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Diouf, Ibrahima
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva
    Trojano, Maria
    Ayuso, Guillermo Izquierdo
    Eichau, Sara
    Onofrj, Marco
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Grand'Maison, Francois
    Sola, Patrizia
    Ferraro, Diana
    Shaygannejad, Vahid
    Alroughani, Raed
    Hupperts, R. M. M.
    Terzi, Murat
    Boz, Cavit
    Lechner-Scott, Jeannette
    Cartechini, Elisabetta
    Van Pesch, Vincent
    Iuliano, Gerardo
    Granella, Franco
    Bergamaschi, Roberto
    Fernandez Bolanos, Ricardo
    Spitaleri, Daniele Litterio A.
    Slee, Mark
    Vucic, Ostoja
    Ampapa, Radek
    McCombe, Pamela
    Ramo-Tello, Cristina
    Petersen, Thor
    Verheul, Freek
    Prevost, Julie
    Olascoaga Urtaza, Francisco Javier
    Cristiano, Edgardo
    Butzkueven, Helmut
    NEUROLOGY, 2020, 94 (15)
  • [8] Assessing a predictive score for long-term disability progression in relapsing-remitting multiple sclerosis: 7/8-year follow-up in the PRISMS study
    Freedman, M.
    Ben-Amor, A-F
    Aycardi, E.
    Issard, D.
    Casset-Semanaz, F.
    Sormani, M-P
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 402 - 403
  • [9] Predictive value of the multiple sclerosis functional composite in relapsing-remitting Multiple Sclerosis: Results of a long-term follow-up study
    Rudick, RA
    Cutter, G
    Baier, M
    Dougherty, DS
    Weinstock-Guttman, B
    Mass, MK
    Fisher, E
    Miller, DM
    Simonian, NA
    NEUROLOGY, 2000, 54 (07) : A215 - A215
  • [10] Long-Term Follow-Up of Laquinimod 0.6 mg in Patients with Relapsing-Remitting Multiple Sclerosis 2
    Comi, Giancarlo
    Vollmer, Timothy
    Lublin, Fred
    Dadon, Yuval
    Gorfine, Tali
    Davis, Mat
    Sorensen, Per Soelberg
    Knappertz, Volker
    NEUROLOGY, 2016, 86
12345